BEGO

Germany · www.bego.com · 13 vendors

Resilience scores

Technology vendors

Services catalogue

2 services in catalogue across 1 category; runs on 13 sub-vendors.

Insights

Last updated 2026-08-06 · revision 1

13 direct vendors, 182 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 6/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

BEGO exhibits a moderate level of migration readiness, primarily supported by its internal tech stack which includes modern and cloud-friendly technologies such as Python, Node.js, React, Angular, REST APIs, and DevOps practices. The use of standard databases like SQL Server and PostgreSQL also facilitates migration paths. However, the assessment is hampered by several unknowns and potential challenges. There is no explicit indication of cloud-native architecture, containerization, or microservices adoption, which might necessitate significant re-architecture efforts for optimal cloud performance and scalability. Crucially, the 'Unknown' vendor lock-in risk poses a significant challenge, as high lock-in could complicate vendor transitions, data migration, and overall re-platforming efforts. While 'Total Vendors' is listed as 0, the existence of 13 services implies vendor relationships, making the unknown lock-in risk a key factor. Furthermore, the absence of specified regulatory environment and data residency requirements introduces uncertainty regarding potential compliance hurdles during a migration.

Compliance

11 in-scope frameworks identified; showing 3.

ISO 27001 (source) — Assessment Required

ISO 27001 is not mandatory for BEGO but is highly relevant given: (1) BEGO operates multiple digital portals processing dental design data and customer personal data; (2) NIS2 compliance (which is mandatory) strongly encourages or effectively requires ISO 27001-equivalent controls; (3) BEGO's CAD/CAM and implantology portals handle sensitive patient-linked data; (4) BEGO's customers (dental laboratories, clinicians) increasingly require supply chain security assurances. The risk is Medium because: (1) absence of ISO 27001 certification creates a gap in demonstrable information security governance; (2) NIS2 enforcement will likely require documented cybersecurity risk management that ISO 27001 would satisfy; (3) BEGO's competitors in the dental technology space are increasingly ISO 27001 certified. The risk is not High because ISO 27001 is voluntary and BEGO's primary regulatory obligations are met through ISO 13485 (which includes some information security elements for medical device software).

Evidence: https://www.bego.com/media-library/download-center/certificates/

FDA 21 CFR Part 820 — Compliant

BEGO's MDSAP certification (2024) satisfies FDA Quality System Regulation requirements for medical device manufacturers selling in the US market. BEGO USA Inc. (Lincoln, RI) distributes BEGO products in the United States. The FDA has accepted MDSAP audit reports in lieu of FDA inspections since 2019. The risk is Low because MDSAP certification is confirmed and current.

Evidence: https://www.bego.com/media-library/download-center/certificates/, https://www.bego.com/fileadmin/user_downloads/Mediathek/Certificates/BEGO-Bremer-Goldschlaegerei/BEGO-Bremer-Goldschlaegerei_Zertifikat-MDSAP_2024.pdf

ISO 13485 — Compliant

ISO 13485:2016 certification is confirmed for all three main BEGO manufacturing entities. This is the internationally recognized standard for quality management systems specific to medical device manufacturers and is a prerequisite for MDR compliance and market access in most jurisdictions. The risk is Low because: (1) certification is confirmed and publicly documented; (2) ISO 13485 is audited regularly by accredited certification bodies; (3) BEGO's MDSAP certification (which includes ISO 13485 requirements) is recognized by regulatory authorities in the USA (FDA), Canada (Health Canada), Australia (TGA), Brazil (ANVISA), and Japan (PMDA).

Evidence: https://www.bego.com/media-library/download-center/certificates/, https://www.bego.com/fileadmin/user_downloads/Mediathek/Certificates/BEGO-Bremer-Goldschlaegerei/EN-ISO-13485_BEGO-DEN_2024_DE-EN.pdf, https://www.bego.com/fileadmin/user_downloads/Mediathek/Certificates/BEGO-Medical/EN_ISO_13485_2016.pdf, https://www.bego.com/fileadmin/user_downloads/Mediathek/Certificates/BEGO-Implant-Systems/EN-ISO-13485_IMP_DE-EN_2024.pdf

Financials

Three-year financials

Financial Resilience Score: 7/10

BEGO demonstrates strong qualitative financial resilience despite the absence of publicly disclosed financial figures. As a family-owned Mittelstand company in its sixth generation of Herbst/Weiss ownership since 1890, BEGO benefits from long-term orientation, disciplined reinvestment, and freedom from short-term listed-market pressure. Its 135+ years of brand equity, 'Made in Germany' manufacturing base in Bremen, and recognition as a German TOP 100 innovator underpin a durable competitive position in the professional dental channel. The group's diversified product portfolio spans the full digital dental value chain — legacy casting alloys and investment materials (cash-generative), CAD/CAM services via BEGO Medical, implantology through BEGO Semados®, 3D-printing resins (Varseo family), and regenerative products (naturesQue). This multi-pillar structure provides several growth vectors that partially offset cyclicality in any one segment. A global distribution footprint across 100+ countries with own subsidiaries on three continents further diversifies geographic risk. However, resilience is tempered by significant competitive intensity from much larger listed players (Straumann, Envista/Nobel Biocare, Dentsply Sirona, 3Shape, Formlabs Dental) whose scale and R&D budgets dwarf BEGO's. Concentration on a single end-market (dentistry), exposure to EU MDR and FDA regulatory cost inflation, precious-metal commodity exposure, and geopolitical risk from Russia/China operations all constrain the resilience score. Limited public financial transparency also increases counterparty diligence friction.

Key strengths: Family-owned across six generations (since 1890) with long-term orientation, Diversified portfolio across conventional alloys, CAD/CAM, implantology, and 3D printing, Made-in-Germany manufacturing with in-house SLM, high-speed milling, and 3D printing, Global footprint in 100+ countries with own subsidiaries on three continents, 135+ years of brand equity in professional dental channel, Recognition as German TOP 100 innovator, Over 600 employees worldwide

Risk factors: Limited public financial transparency as a private GmbH & Co. KG, Single end-market concentration in dentistry with reimbursement/cyclicality exposure, Competitive intensity from much larger listed dental competitors (Straumann, Dentsply Sirona, 3Shape, etc.), EU MDR and FDA regulatory compliance cost inflation, Precious-metal (gold, platinum, palladium) input price volatility, Geopolitical risk from Russia and China operations

Revenue by geography

Revenue by product/service

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report